Case Studies

An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...

Recent Blog Posts

September 3, 2010 |

Partnership to Improve Patient Care (PIPC) Chairman Tony Coelho was quoted in an Inside Health Policy article this week discussing his concerns on the Department of Health and Human Service’s (HHS) plans to build a CER inventory before the creation of the Patient Centered Outcomes and Research Institute, an independent board that will facilitate CER research.

| Read More
September 3, 2010 |

The latest addition of Congressional Quarterly (CQ) features an article on comparative effectiveness research (CER) in which Partnership to Improve Patient Care (PIPC) Chairman Tony Coelho weighs in on the issue.

| Read More
August 16, 2010 |

Partnership to Improve Patient Care Chairman Tony Coelho recently sent a letter to Sherry Glied, the Assistant Secretary for Planning and Evaluation at the Department of Health and Human Services (HHS), recommending that the Agency work closely with the Patient Centered Outcomes and Research Institute when building its planned nationwide CER database.

| Read More

For Reporters

For journalists and other media professionals

More Information

Stay Connected

oncologist

Oncologist believes CER can’t ‘keep pace with advances in medicine’—shouldn’t get between doctor and patient

| Posted in:

A recent op-ed in the Wall Street Journal by Dr. Leonard Zwelling, illustrates why treatment decisions must stay between a patient and their doctor and reinforces the importance of the comparative effectiveness research (CER) language included in the recently passed Patient Protection and Affordable Care Act.


Zwelling, an oncologist, explains the challenges of using CER to set rigid national policy requirements. He highlights how cancer care is continually evolving in that it allows doctors to better address the individual needs of cancer patients whose bodies react to their forms of cancers in different ways than those of other patients:

Syndicate content